Prana Biotechnology PE Ratio 2010-2022 | ATHE
Current and historical p/e ratio for Prana Biotechnology (ATHE) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Prana Biotechnology PE ratio as of February 03, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Prana Biotechnology PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2023-02-03 |
3.95 |
|
inf |
| 2022-06-30 |
6.11 |
0 |
0.00 |
| 2021-12-31 |
7.20 |
0 |
0.00 |
| 2021-06-30 |
13.00 |
0 |
0.00 |
| 2020-12-31 |
13.40 |
0 |
0.00 |
| 2020-06-30 |
11.90 |
0 |
0.00 |
| 2019-12-31 |
7.80 |
0 |
0.00 |
| 2019-06-30 |
13.10 |
0 |
0.00 |
| 2018-12-31 |
12.80 |
0 |
0.00 |
| 2018-06-30 |
18.89 |
0 |
0.00 |
| 2017-12-31 |
31.20 |
0 |
0.00 |
| 2017-06-30 |
22.90 |
0 |
0.00 |
| 2016-06-30 |
47.42 |
0 |
0.00 |
| 2015-12-31 |
43.44 |
0 |
0.00 |
| 2015-06-30 |
70.20 |
0 |
0.00 |
| 2014-12-31 |
98.40 |
0 |
0.00 |
| 2014-06-30 |
135.90 |
0 |
0.00 |
| 2013-12-31 |
420.60 |
0 |
0.00 |
| 2013-06-30 |
139.20 |
0 |
0.00 |
| 2012-12-31 |
132.00 |
0 |
0.00 |
| 2012-06-30 |
94.20 |
0 |
0.00 |
| 2011-12-31 |
88.20 |
0 |
0.00 |
| 2011-06-30 |
114.60 |
0 |
0.00 |
| 2010-12-31 |
75.00 |
0 |
0.00 |
| 2010-06-30 |
67.20 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.016B |
$0.003B |
|
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.
|
